Emergent BioSolutions Inc.
EBS
$11.60
$0.756.91%
NYSE
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 64.02% | -36.59% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 64.02% | -36.59% | |||
| Cost of Revenue | 23.44% | -21.98% | |||
| Gross Profit | 117.63% | -49.16% | |||
| SG&A Expenses | -35.68% | -16.51% | |||
| Depreciation & Amortization | 0.62% | -0.61% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.42% | -18.28% | |||
| Operating Income | 17,360.00% | -99.01% | |||
| Income Before Tax | 442.86% | -118.12% | |||
| Income Tax Expenses | 233.33% | -119.43% | |||
| Earnings from Continuing Operations | 526.67% | -117.65% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 526.67% | -117.65% | |||
| EBIT | 17,360.00% | -99.01% | |||
| EBITDA | 369.36% | -68.75% | |||
| EPS Basic | 534.69% | -117.71% | |||
| Normalized Basic EPS | 489.34% | -118.43% | |||
| EPS Diluted | 511.02% | -118.61% | |||
| Normalized Diluted EPS | 466.57% | -119.41% | |||
| Average Basic Shares Outstanding | -1.85% | -0.37% | |||
| Average Diluted Shares Outstanding | 4.24% | -5.41% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||